Characteristics and Outcomes of Patients with Heart Failure and History of Malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register
Pietro Ameri(Ospedale Policlinico San Martino), Gianluigi Savarese(Karolinska Institutet), Lina Benson(Karolinska Institutet), Charlotta Ljungman(Swedish Academy), Davide Stolfo(Azienda Ospedaliero Universitaria Ospedali Riuniti), Lars H. Lund(Karolinska University Hospital), Felix Lindberg(Karolinska Institutet), Javed Butler(Emory University), Kalliopi Keramida(National and Kapodistrian University of Athens), P. Costa(Karolinska Institutet), Nicolas Girerd(Inserm), Stefan D. Anker(Deutsches Herzzentrum der Charité), Nabil V. Sayour(Semmelweis University)
Cited by 7
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
Mitochondrial function as a therapeutic target in heart failure
|Nature Reviews Cardiology|2016|786
Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction
|Journal of the American College of Cardiology|2014|541